Evolution 1998-2002 of the antidepressant consumption in France, Germany and the United Kingdom
The aim of this paper is to compare the evolution of antidepressant consumption in France, Germany and the United Kingdom between 1998 and 2002. Commercial databases (IMS Health) have been used in conjunction with administrative data (PACT for the UK, GKV for Germany and Afssaps for France) to estimate antidepressant consumption in Daily Defined Doses. The main results are: (1) Antidepressant consumption has increased significantly over the last decade in France (x2), Germany (x2.4) and the UK (x3.8); (2) SSRIs are the most heavily consumed drugs in France (67%) and the UK (60%); (3) Germany is distinguished by an overall level of antidepressant consumption twice as low as the other two countries and a relatively low use of SSRI antidepressants (31%), in favour of TCAs. In conclusion, the combined use of administrative and commercial data is possible for an evaluation of the volume of consumption. This study sheds both medical and economic light on the differences in both the level and structure of consumption in these three countries.
|Date of creation:||Feb 2009|
|Date of revision:||Feb 2009|
|Contact details of provider:|| Postal: 117bis rue Manin, 75019 Paris|
Phone: 33 1 53 93 43 00
Fax: 33 1 53 93 43 50
Web page: http://www.irdes.fr
More information through EDIRC
When requesting a correction, please mention this item's handle: RePEc:irh:wpaper:dt21. See general information about how to correct material in RePEc.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: (Jacques Harrouin)
If references are entirely missing, you can add them using this form.